Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$109M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$89.4M |
| 3 |
JPMorgan Chase
JPM
|
+$82.7M |
| 4 |
Intel
INTC
|
+$73.6M |
| 5 |
Boston Scientific
BSX
|
+$72.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American International
AIG
|
+$193M |
| 2 |
RTX Corp
RTX
|
+$170M |
| 3 |
PNC Financial Services
PNC
|
+$126M |
| 4 |
ExxonMobil
XOM
|
+$121M |
| 5 |
Bank of America
BAC
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.65% |
| 2 | Technology | 14.28% |
| 3 | Financials | 13.93% |
| 4 | Consumer Discretionary | 13.37% |
| 5 | Industrials | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRUB
51
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $32.4M | 0.38% |
+398,307
| New | +$39.2M |
|
52
WEX
WEX
$6.81B
| $32.2M | 0.38% |
307,694
+176,296
| +134% | +$32.9M |
|
53
Pentair
PNR
$10.3B
| $31.4M | 0.37% |
1,056,672
+423,427
| +67% | +$17M |
|
54
Saic
SAIC
$5.41B
| $31.4M | 0.37% |
421,310
+322,646
| +327% | +$26.9M |
|
55
Melco Resorts & Entertainment
MLCO
$2.09B
| $31.4M | 0.37% |
2,533,192
+745,221
| +42% | +$14.2M |
|
|
TIF
56
DELISTED
Tiffany & Co.
TIF
| $31.4M | 0.37% |
242,303
-339,683
| -58% | -$44.7M |
|
57
BioMarin Pharmaceuticals
BMRN
$12.9B
| $31M | 0.37% |
366,292
-258,125
| -41% | -$22.2M |
|
|
OPTU
58
Optimum Communications Inc
OPTU
$323M
| $30.7M | 0.36% |
1,379,203
-879,106
| -39% | -$23M |
|
59
Akamai
AKAM
$15.9B
| $30.4M | 0.36% |
332,767
-172,732
| -34% | -$16M |
|
|
CONE
60
DELISTED
CyrusOne Inc Common Stock
CONE
| $30.3M | 0.36% |
+490,755
| New | +$30M |
|
61
Madison Square Garden
MSGS
$9.78B
| $30.3M | 0.36% |
200,719
+36,699
| +22% | +$7.12M |
|
62
CVS Health
CVS
$119B
| $30.1M | 0.36% |
507,297
+179,133
| +55% | +$12M |
|
63
DexCom
DXCM
$34.8B
| $29.5M | 0.35% |
438,344
-24,972
| -5% | -$1.55M |
|
64
Williams Companies
WMB
$86.2B
| $29.5M | 0.35% |
2,083,039
+1,985,799
| +2,042% | +$38.5M |
|
65
Altria Group
MO
$110B
| $29.2M | 0.35% |
+754,763
| New | +$33.5M |
|
66
Lam Research
LRCX
$393B
| $29.2M | 0.35% |
1,215,560
+64,350
| +6% | +$1.85M |
|
67
Blackrock
BLK
$179B
| $28.9M | 0.34% |
65,643
+50,877
| +345% | +$25.1M |
|
68
Allstate
ALL
$64.2B
| $28.7M | 0.34% |
+313,089
| New | +$34M |
|
69
PUT
Biogen
BIIB
$32B
| $28.5M | 0.34% |
+90,000
| New | +$27.3M |
|
70
Sanofi
SNY
$110B
| $28.4M | 0.34% |
650,092
+6,818
| +1% | +$326K |
|
|
NVO
71
Novo Nordisk
NVO
$207B
| $28.1M | 0.33% |
934,456
-459,528
| -33% | -$13.7M |
|
72
PUT
State Street Utilities Select Sector SPDR ETF
XLU
$22.2B
| $28M | 0.33% |
+1,012,000
| New | +$32.4M |
|
73
Archer Daniels Midland
ADM
$38.7B
| $27.5M | 0.33% |
782,180
+111,500
| +17% | +$4.56M |
|
74
ASML
ASML
$677B
| $27.4M | 0.33% |
104,813
+50,612
| +93% | +$14.4M |
|
|
CXO
75
DELISTED
CONCHO RESOURCES INC.
CXO
| $27.3M | 0.32% |
636,192
+301,300
| +90% | +$21M |
|
Similar funds
Dmitry Balyasny's Q1 2020 Portfolio in Review
As of Q1 2020, Dmitry Balyasny held 1,704 positions worth $8.43B, down 50% from $16.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dmitry Balyasny withdrew a net $5.17B in Q1 2020, closing 598 positions and reducing 300 holdings. Its most notable exit was American International, an estimated $193M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 11% a quarter earlier, followed by Technology and Financials.
Against the trend, Dmitry Balyasny opened a new position in Lowe's Companies worth $86M.
- Dmitry Balyasny's largest Q1 2020 buy was Lowe's Companies: 999,686 shares worth $86M.
- Dmitry Balyasny added most to Boston Scientific in Q1 2020, an estimated $72.4M increase.
- Dmitry Balyasny's biggest Q1 2020 reduction was ExxonMobil, cutting an estimated $121M.
- Dmitry Balyasny fully exited American International in Q1 2020, selling an estimated $193M.
- Dmitry Balyasny's ten largest holdings make up 11% of its $8.43B portfolio in Q1 2020.
- Dmitry Balyasny opened 583 new positions and closed 598 in Q1 2020.
- Dmitry Balyasny's portfolio value fell 50% quarter-over-quarter to $8.43B.
Based on Balyasny Asset Management's 13F filing for Q1 2020, filed 15 May 2020.